Equity copertina

Equity

Equity

Di: TechCrunch Rebecca Bellan Kirsten Korosec Anthony Ha Sean O'Kane Theresa Loconsolo
Ascolta gratuitamente

A proposito di questo titolo

 The intersection of technology, startups, and venture capital touches everything now. That’s why Equity, TechCrunch's flagship podcast, digs into the business of startups for entrepreneurs and enthusiasts alike. Every Wednesday and Friday, TechCrunch reporters keep you up-to-date on the world of business, technology, and venture capital. Equity is ranked the No.2 podcast in the Top 100 Venture Capital All time leaderboard on Goodpods—As well as No.17 for the Top 100 Finance All time chart and No.32 for the Top 100 Business News All time chart. Economia Gestione e leadership Leadership Politica e governo
Episodi
  • Fusion doesn't have a normal startup timeline, and investors are fine with that

    Fusion doesn't have a normal startup timeline, and investors are fine with that
    Apr 22 2026
    Fusion energy has been "20 years away" for decades, but has the science finally caught up? Private investment in fusion companies surged from $10 billion to $15 billion in just months, and the money is coming from places you wouldn't expect. On this episode of TechCrunch's Equity podcast, Rebecca Bellan and guest host Tim De Chant sit down with Rachel Slaybaugh, general partner at DCVC, to break down why serious investors are finally treating fusion as a real asset class, and what the return thesis actually looks like when no one expects a power plant in their fund lifetime. Listen to the full episode to hear about: Why the investment thesis for fusion looks less like traditional VC and more like biotech or SpaceX, and what "fusion euphoria" has to do with it What the Q value milestone actually means, and how close leading startups are to hitting the number that could trigger a public market opening How superconducting tape and AI-assisted plasma physics are quietly doing as much work as the big headline science breakthroughs Why one fusion company merging with Trump Media and Technology Group had Tim doing a double-take at his inbox Subscribe to Equity on YouTube, Apple Podcasts, Overcast, Spotify and all the casts. You also can follow Equity on X and Threads, at @EquityPod. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Mostra di più Mostra meno
    34 min
  • Tokenmaxxing, OpenAI's shopping spree, and the AI Anxiety Gap

    Tokenmaxxing, OpenAI's shopping spree, and the AI Anxiety Gap
    Apr 17 2026
    The gap between AI insiders and everyone else is widening, and the spending, suspicion, and even new vocabulary are starting to show it. While OpenAI is busy buying up everything from finance apps to talk shows, a certain shoe company just rebranded as an AI infrastructure play, and Anthropic unveiled a model it says is too powerful to release publicly ...but apparently not too powerful to demo to Federal Reserve Chair Jerome Powell. On this episode of TechCrunch's Equity podcast, Kirsten Korosec, Anthony Ha, and Sean O'Kane dig into what's actually being built in AI infrastructure, who's winning the enterprise battle between OpenAI and Anthropic, and more of the week's headlines. Listen to the full episode to hear about: Why chipmakers AMD, Arm, and Qualcomm just piled $60M into UK self-driving startup Wayve, and what Uber's $300M milestone bid says about who's winning the AV race How data center startup Fluidstack is positioning itself for the frontier labs, including a reported $50B agreement with Anthropic What Claude Code's moment at the HumanX conference reveals about where the OpenAI vs. Anthropic rivalry is actually playing out Why tokenmaxxing, and Meta's leaked internal leaderboard, might say more about optics than actual productivity Subscribe to Equity on YouTube, Apple Podcasts, Overcast, Spotify and all the casts. You also can follow Equity on X and Threads, at @EquityPod. Chapters: 00:00 Intro 00:25 Allbirds is now an AI company, apparently 04:48 Why chipmakers are betting on Wayve 12:01 Fluidstack wants $1B to build AI data centers 16:24 OpenAI buys a finance app and a talk show 21:27 Anthropic vs. OpenAI in enterprise 24:15 The Anthropic model they won't release to the public 26:47 Why AI feels so distant to everyone else 30:47 What even is tokenmaxxing? 34:49 Parasail's $32M bet on cheaper AI inference 36:39 Outro Learn more about your ad choices. Visit megaphone.fm/adchoices
    Mostra di più Mostra meno
    39 min
  • The musician-turned-biotech-founder waiting to fundraise

    The musician-turned-biotech-founder waiting to fundraise
    Apr 15 2026
    When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can't just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn't move science through clinical trials or get you a license on university IP. Now, he's bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that kills 90% of its patients, and intentionally waiting to raise from his network until peer-reviewed papers can make his case. On this episode of TechCrunch's Equity podcast, Rebecca Bellan sits down with Aloe Blacc to talk about what happens when a creator decides to build instead of just invest, how Aloe is watching AI reshape both the biotech and music industries in real time, and his thoughts on who actually wins. Listen to the full episode to hear: How he’s navigating a world where credibility is earned in data, not fame How a University of Houston molecule discovery platform could cut years off drug development timelines Why he thinks record labels, not artists or AI companies, will ultimately control the economics of AI-generated music What Suno taught him about prototyping, and why his next album will still be recorded with live musicians Subscribe to Equity on YouTube, Apple Podcasts, Overcast, Spotify and all the casts. You also can follow Equity on X and Threads, at @EquityPod. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Mostra di più Mostra meno
    29 min
Ancora nessuna recensione